English
English Indonesia Türkçe Deutsch Español Português Pусский Français Italiano Nederlands Polski العربية ไทย Tiếng Việt 繁體中文 简体中文 日本語 한국어

#precisiononc search results

schlayguy's profile picture. Schlayguy is a genomic tech pioneer and cryptic NFT artist, disrupting legacy systems with SeqSwift—ultra-fast, privacy-first DNA analysis (full GRCh.38 in 80s)
Schlayballs
 @schlayguy
Dec 4

Schlayballs has spoken. Live Miracles - Sepsis DX in sub-seconds. HPV18 oncology panel 6,900,000 mutations → 185 ms $140 Chromebook. No GPU. No cloud. Live terminal proof - Light enters @illumina @schlayguy #Seqswift #Precisiononc #illumina vimeo.com/1143284512

schlayguy's tweet image. Schlayballs has spoken. Live Miracles - Sepsis DX in sub-seconds. HPV18 oncology panel 6,900,000 mutations → 185 ms $140 Chromebook. No GPU. No cloud. Live terminal proof - Light enters @illumina @schlayguy #Seqswift #Precisiononc #illumina vimeo.com/1143284512
0
0
0
0
43
aftimosp's profile picture. Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Citizen of wokistan. Ecolo and vegan💚🌱Oud 🎼 💛💙⚽️Views are mine.
Philippe Aftimos, MD 
 @aftimosp
Apr 14, 2018

Current status of @theNCI MATCH and what we will potentially learn #AACR18 #PrecisionMedicine #PrecisionOnc

aftimosp's tweet image. Current status of @theNCI MATCH and what we will potentially learn #AACR18 #PrecisionMedicine #PrecisionOnc
aftimosp's tweet image. Current status of @theNCI MATCH and what we will potentially learn #AACR18 #PrecisionMedicine #PrecisionOnc
0
5
6
0
0
shilpaonc's profile picture. GU oncologist, clinical trialist. Director, GU Oncology @CleclinicMD Tweets my own, RT/Likes not active endorsement.
Shilpa Gupta
@shilpaonc
Apr 19, 2024

@eevokes highlights the efficacy of #enfortumab vedotin in Head & Neck Ca, RR ~ 20% Highlights the standing ovation for EV-pembro in EV302 @myESMO @tompowles1 @DrRosenbergMSK @PGrivasMDPhD @BrainTumorDoc @MiamiCancerInst #PrecisionOnc Symposium

shilpaonc's tweet image. @eevokes highlights the efficacy of #enfortumab vedotin in Head & Neck Ca, RR ~ 20% Highlights the standing ovation for EV-pembro in EV302 @myESMO @tompowles1 @DrRosenbergMSK @PGrivasMDPhD @BrainTumorDoc @MiamiCancerInst #PrecisionOnc Symposium
1
5
12
0
738
aftimosp's profile picture. Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Citizen of wokistan. Ecolo and vegan💚🌱Oud 🎼 💛💙⚽️Views are mine.
Philippe Aftimos, MD 
 @aftimosp
Apr 14, 2018

Lessons learned from the @theNCI MATCH study: what works and what needs more work #AACR18 #precisionmedicine #PrecisionOnc

aftimosp's tweet image. Lessons learned from the @theNCI MATCH study: what works and what needs more work #AACR18 #precisionmedicine #PrecisionOnc
aftimosp's tweet image. Lessons learned from the @theNCI MATCH study: what works and what needs more work #AACR18 #precisionmedicine #PrecisionOnc
0
2
3
0
0
JCO_ASCO's profile picture. @ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, @JCOPO_ASCO, @JCOOA_ASCO.
Journal of Clinical Oncology
@JCO_ASCO
Feb 19, 2021

Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology fal.cn/3dw7L #precisiononc #JCOPO

JCO_ASCO's tweet image. Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology fal.cn/3dw7L #precisiononc #JCOPO
0
10
26
2
0
aftimosp's profile picture. Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Citizen of wokistan. Ecolo and vegan💚🌱Oud 🎼 💛💙⚽️Views are mine.
Philippe Aftimos, MD 
 @aftimosp
Apr 14, 2018

A “decentralized” testing approach was added in @theNCI MATCH to improve the inclusion of rare variants #AACR18 #PrecisionMedicine #PrecisionOnc

aftimosp's tweet image. A “decentralized” testing approach was added in @theNCI MATCH to improve the inclusion of rare variants #AACR18 #PrecisionMedicine #PrecisionOnc
aftimosp's tweet image. A “decentralized” testing approach was added in @theNCI MATCH to improve the inclusion of rare variants #AACR18 #PrecisionMedicine #PrecisionOnc
0
3
4
0
0
aftimosp's profile picture. Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Citizen of wokistan. Ecolo and vegan💚🌱Oud 🎼 💛💙⚽️Views are mine.
Philippe Aftimos, MD 
 @aftimosp
Apr 14, 2018

Pre-requisites for successful matching using MatchMiner: both referring oncoloist and trial investigator have a role #PrecisionMedicine #PrecisionOnc #AACR18

aftimosp's tweet image. Pre-requisites for successful matching using MatchMiner: both referring oncoloist and trial investigator have a role #PrecisionMedicine #PrecisionOnc #AACR18
0
1
2
0
0
aftimosp's profile picture. Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Citizen of wokistan. Ecolo and vegan💚🌱Oud 🎼 💛💙⚽️Views are mine.
Philippe Aftimos, MD 
 @aftimosp
Apr 14, 2018

.@obigriffith explains henomoc variants’ significance in cancer and gives examples #PrecisionMedicine #PrecisionOnc #AACR18

aftimosp's tweet image. .@obigriffith explains henomoc variants’ significance in cancer and gives examples #PrecisionMedicine #PrecisionOnc #AACR18
1
2
4
0
0
UGrewalMD's profile picture. GI Oncologist @WinshipAtEmory via @uiowacancer #GIOncology/#NETs, clinical trials, cardiac disease in cancer 🦓🎗️@TheGutOncLab
Udhayvir Grewal
@UGrewalMD
Jun 4, 2023

Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa

UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa
UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa
UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa
UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa
0
6
21
0
2K
aftimosp's profile picture. Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Citizen of wokistan. Ecolo and vegan💚🌱Oud 🎼 💛💙⚽️Views are mine.
Philippe Aftimos, MD 
 @aftimosp
Apr 14, 2018

Homogeneous structuring of eligibility criteria accross trials is needed for efficient trial matching, thus Clinical Trial Markup Language (CTML) #PrecisionMedicine #PrecisionOnc #AACR18

aftimosp's tweet image. Homogeneous structuring of eligibility criteria accross trials is needed for efficient trial matching, thus Clinical Trial Markup Language (CTML) #PrecisionMedicine #PrecisionOnc #AACR18
aftimosp's tweet image. Homogeneous structuring of eligibility criteria accross trials is needed for efficient trial matching, thus Clinical Trial Markup Language (CTML) #PrecisionMedicine #PrecisionOnc #AACR18
aftimosp's tweet image. Homogeneous structuring of eligibility criteria accross trials is needed for efficient trial matching, thus Clinical Trial Markup Language (CTML) #PrecisionMedicine #PrecisionOnc #AACR18
0
0
1
0
0
UGrewalMD's profile picture. GI Oncologist @WinshipAtEmory via @uiowacancer #GIOncology/#NETs, clinical trials, cardiac disease in cancer 🦓🎗️@TheGutOncLab
Udhayvir Grewal
@UGrewalMD
Oct 13, 2023

Excellent virtual lecture on reimagining clinical trials in #precisiononc era by the amazing Dr @Dr_R_Kurzrock this morning. Truly inspirational! It was really an “avalanche of wisdom” as it was described by the audience. Thanks @ZakhariaYousef @UIowaCancer for organizing this.

UGrewalMD's tweet image. Excellent virtual lecture on reimagining clinical trials in #precisiononc era by the amazing Dr @Dr_R_Kurzrock this morning. Truly inspirational! It was really an “avalanche of wisdom” as it was described by the audience. Thanks @ZakhariaYousef @UIowaCancer for organizing this.
0
2
13
0
5K
JCO_ASCO's profile picture. @ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, @JCOPO_ASCO, @JCOOA_ASCO.
Journal of Clinical Oncology
@JCO_ASCO
Feb 13, 2021

Risk and benefit in early oncology trials in the era of precision medicine revisited fal.cn/3do7M #precisiononc #JCOPO

JCO_ASCO's tweet image. Risk and benefit in early oncology trials in the era of precision medicine revisited fal.cn/3do7M #precisiononc #JCOPO
0
0
9
0
0
aftimosp's profile picture. Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Citizen of wokistan. Ecolo and vegan💚🌱Oud 🎼 💛💙⚽️Views are mine.
Philippe Aftimos, MD 
 @aftimosp
Apr 14, 2018

.@obigriffith shows the current content of CIViC and the list of contributors #PrecisionMedicine #PrecisionOnc #AACR18

aftimosp's tweet image. .@obigriffith shows the current content of CIViC and the list of contributors #PrecisionMedicine #PrecisionOnc #AACR18
aftimosp's tweet image. .@obigriffith shows the current content of CIViC and the list of contributors #PrecisionMedicine #PrecisionOnc #AACR18
0
1
0
0
0
JCO_ASCO's profile picture. @ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, @JCOPO_ASCO, @JCOOA_ASCO.
Journal of Clinical Oncology
@JCO_ASCO
May 27, 2021

Use of a modular data warehouse to enable precision medicine in cancer care fal.cn/3fFYp #JCOCCI #precisiononc

JCO_ASCO's tweet image. Use of a modular data warehouse to enable precision medicine in cancer care fal.cn/3fFYp #JCOCCI #precisiononc
0
0
1
0
0
ThejusJay's profile picture. Gastrointestinal Oncologist at @DanaFarber @Harvardmed via @ClevelandClinic @CCFhemonc @AHNIMres & @aiims_newdelhi #earlyonsetcancers #multiomics 📚🚴
Thejus Jayakrishnan
 @ThejusJay
Feb 10, 2024

Must read for anyone trying to gain a deep understanding of NGS testing. Provides a great overview of the workflow, DNA vs. RNA seq, & terminology descriptions. Molecular profiling in #cholangiocarcinoma: A practical guide to next-g... sciencedirect.com/science/articl… #precisiononc

ThejusJay's tweet image. Must read for anyone trying to gain a deep understanding of NGS testing. Provides a great overview of the workflow, DNA vs. RNA seq, & terminology descriptions. Molecular profiling in #cholangiocarcinoma: A practical guide to next-g... sciencedirect.com/science/articl… #precisiononc
0
6
31
16
3K
JCO_ASCO's profile picture. @ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, @JCOPO_ASCO, @JCOOA_ASCO.
Journal of Clinical Oncology
@JCO_ASCO
Mar 22, 2021

Review article: OncoTree community-driven cancer classification system for precision oncology fal.cn/3ecaJ #JCOCCI #precisiononc

JCO_ASCO's tweet image. Review article: OncoTree community-driven cancer classification system for precision oncology fal.cn/3ecaJ #JCOCCI #precisiononc
0
3
2
0
0
No results for "#precisiononc"
aftimosp's profile picture. Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Citizen of wokistan. Ecolo and vegan💚🌱Oud 🎼 💛💙⚽️Views are mine.
Philippe Aftimos, MD 
 @aftimosp
Apr 14, 2018

Current status of @theNCI MATCH and what we will potentially learn #AACR18 #PrecisionMedicine #PrecisionOnc

aftimosp's tweet image. Current status of @theNCI MATCH and what we will potentially learn #AACR18 #PrecisionMedicine #PrecisionOnc
aftimosp's tweet image. Current status of @theNCI MATCH and what we will potentially learn #AACR18 #PrecisionMedicine #PrecisionOnc
0
5
6
0
0
JCO_ASCO's profile picture. @ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, @JCOPO_ASCO, @JCOOA_ASCO.
Journal of Clinical Oncology
@JCO_ASCO
Feb 19, 2021

Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology fal.cn/3dw7L #precisiononc #JCOPO

JCO_ASCO's tweet image. Inherited Susceptibility to Hematopoietic Malignancies in the Era of Precision Oncology fal.cn/3dw7L #precisiononc #JCOPO
0
10
26
2
0
aftimosp's profile picture. Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Citizen of wokistan. Ecolo and vegan💚🌱Oud 🎼 💛💙⚽️Views are mine.
Philippe Aftimos, MD 
 @aftimosp
Apr 14, 2018

Lessons learned from the @theNCI MATCH study: what works and what needs more work #AACR18 #precisionmedicine #PrecisionOnc

aftimosp's tweet image. Lessons learned from the @theNCI MATCH study: what works and what needs more work #AACR18 #precisionmedicine #PrecisionOnc
aftimosp's tweet image. Lessons learned from the @theNCI MATCH study: what works and what needs more work #AACR18 #precisionmedicine #PrecisionOnc
0
2
3
0
0
JCO_ASCO's profile picture. @ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, @JCOPO_ASCO, @JCOOA_ASCO.
Journal of Clinical Oncology
@JCO_ASCO
Feb 13, 2021

Risk and benefit in early oncology trials in the era of precision medicine revisited fal.cn/3do7M #precisiononc #JCOPO

JCO_ASCO's tweet image. Risk and benefit in early oncology trials in the era of precision medicine revisited fal.cn/3do7M #precisiononc #JCOPO
0
0
9
0
0
aftimosp's profile picture. Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Citizen of wokistan. Ecolo and vegan💚🌱Oud 🎼 💛💙⚽️Views are mine.
Philippe Aftimos, MD 
 @aftimosp
Apr 14, 2018

A “decentralized” testing approach was added in @theNCI MATCH to improve the inclusion of rare variants #AACR18 #PrecisionMedicine #PrecisionOnc

aftimosp's tweet image. A “decentralized” testing approach was added in @theNCI MATCH to improve the inclusion of rare variants #AACR18 #PrecisionMedicine #PrecisionOnc
aftimosp's tweet image. A “decentralized” testing approach was added in @theNCI MATCH to improve the inclusion of rare variants #AACR18 #PrecisionMedicine #PrecisionOnc
0
3
4
0
0
aftimosp's profile picture. Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Citizen of wokistan. Ecolo and vegan💚🌱Oud 🎼 💛💙⚽️Views are mine.
Philippe Aftimos, MD 
 @aftimosp
Apr 14, 2018

.@obigriffith explains henomoc variants’ significance in cancer and gives examples #PrecisionMedicine #PrecisionOnc #AACR18

aftimosp's tweet image. .@obigriffith explains henomoc variants’ significance in cancer and gives examples #PrecisionMedicine #PrecisionOnc #AACR18
1
2
4
0
0
JCO_ASCO's profile picture. @ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, @JCOPO_ASCO, @JCOOA_ASCO.
Journal of Clinical Oncology
@JCO_ASCO
May 27, 2021

Use of a modular data warehouse to enable precision medicine in cancer care fal.cn/3fFYp #JCOCCI #precisiononc

JCO_ASCO's tweet image. Use of a modular data warehouse to enable precision medicine in cancer care fal.cn/3fFYp #JCOCCI #precisiononc
0
0
1
0
0
UGrewalMD's profile picture. GI Oncologist @WinshipAtEmory via @uiowacancer #GIOncology/#NETs, clinical trials, cardiac disease in cancer 🦓🎗️@TheGutOncLab
Udhayvir Grewal
@UGrewalMD
Jun 4, 2023

Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa

UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa
UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa
UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa
UGrewalMD's tweet image. Excellent session by my mentor @ChandrikhaC on updates in GI malignancies. I’m stoked about the advances in #precisiononc in GI cancers. The “practice challenging” NORPACT study is perhaps the most intriguing update in PDAC in the recent times. #ASCO23 @UIowaCancer @IntMedatIowa
0
6
21
0
2K
shilpaonc's profile picture. GU oncologist, clinical trialist. Director, GU Oncology @CleclinicMD Tweets my own, RT/Likes not active endorsement.
Shilpa Gupta
@shilpaonc
Apr 19, 2024

@eevokes highlights the efficacy of #enfortumab vedotin in Head & Neck Ca, RR ~ 20% Highlights the standing ovation for EV-pembro in EV302 @myESMO @tompowles1 @DrRosenbergMSK @PGrivasMDPhD @BrainTumorDoc @MiamiCancerInst #PrecisionOnc Symposium

shilpaonc's tweet image. @eevokes highlights the efficacy of #enfortumab vedotin in Head & Neck Ca, RR ~ 20% Highlights the standing ovation for EV-pembro in EV302 @myESMO @tompowles1 @DrRosenbergMSK @PGrivasMDPhD @BrainTumorDoc @MiamiCancerInst #PrecisionOnc Symposium
1
5
12
0
738
JCO_ASCO's profile picture. @ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, @JCOPO_ASCO, @JCOOA_ASCO.
Journal of Clinical Oncology
@JCO_ASCO
Mar 22, 2021

Review article: OncoTree community-driven cancer classification system for precision oncology fal.cn/3ecaJ #JCOCCI #precisiononc

JCO_ASCO's tweet image. Review article: OncoTree community-driven cancer classification system for precision oncology fal.cn/3ecaJ #JCOCCI #precisiononc
0
3
2
0
0
aftimosp's profile picture. Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Citizen of wokistan. Ecolo and vegan💚🌱Oud 🎼 💛💙⚽️Views are mine.
Philippe Aftimos, MD 
 @aftimosp
Apr 14, 2018

Pre-requisites for successful matching using MatchMiner: both referring oncoloist and trial investigator have a role #PrecisionMedicine #PrecisionOnc #AACR18

aftimosp's tweet image. Pre-requisites for successful matching using MatchMiner: both referring oncoloist and trial investigator have a role #PrecisionMedicine #PrecisionOnc #AACR18
0
1
2
0
0
schlayguy's profile picture. Schlayguy is a genomic tech pioneer and cryptic NFT artist, disrupting legacy systems with SeqSwift—ultra-fast, privacy-first DNA analysis (full GRCh.38 in 80s)
Schlayballs
 @schlayguy
Dec 4

Schlayballs has spoken. Live Miracles - Sepsis DX in sub-seconds. HPV18 oncology panel 6,900,000 mutations → 185 ms $140 Chromebook. No GPU. No cloud. Live terminal proof - Light enters @illumina @schlayguy #Seqswift #Precisiononc #illumina vimeo.com/1143284512

schlayguy's tweet image. Schlayballs has spoken. Live Miracles - Sepsis DX in sub-seconds. HPV18 oncology panel 6,900,000 mutations → 185 ms $140 Chromebook. No GPU. No cloud. Live terminal proof - Light enters @illumina @schlayguy #Seqswift #Precisiononc #illumina vimeo.com/1143284512
0
0
0
0
43
aftimosp's profile picture. Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Citizen of wokistan. Ecolo and vegan💚🌱Oud 🎼 💛💙⚽️Views are mine.
Philippe Aftimos, MD 
 @aftimosp
Apr 14, 2018

.@obigriffith shows the current content of CIViC and the list of contributors #PrecisionMedicine #PrecisionOnc #AACR18

aftimosp's tweet image. .@obigriffith shows the current content of CIViC and the list of contributors #PrecisionMedicine #PrecisionOnc #AACR18
aftimosp's tweet image. .@obigriffith shows the current content of CIViC and the list of contributors #PrecisionMedicine #PrecisionOnc #AACR18
0
1
0
0
0
UGrewalMD's profile picture. GI Oncologist @WinshipAtEmory via @uiowacancer #GIOncology/#NETs, clinical trials, cardiac disease in cancer 🦓🎗️@TheGutOncLab
Udhayvir Grewal
@UGrewalMD
Oct 13, 2023

Excellent virtual lecture on reimagining clinical trials in #precisiononc era by the amazing Dr @Dr_R_Kurzrock this morning. Truly inspirational! It was really an “avalanche of wisdom” as it was described by the audience. Thanks @ZakhariaYousef @UIowaCancer for organizing this.

UGrewalMD's tweet image. Excellent virtual lecture on reimagining clinical trials in #precisiononc era by the amazing Dr @Dr_R_Kurzrock this morning. Truly inspirational! It was really an “avalanche of wisdom” as it was described by the audience. Thanks @ZakhariaYousef @UIowaCancer for organizing this.
0
2
13
0
5K
aftimosp's profile picture. Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Citizen of wokistan. Ecolo and vegan💚🌱Oud 🎼 💛💙⚽️Views are mine.
Philippe Aftimos, MD 
 @aftimosp
Apr 14, 2018

Homogeneous structuring of eligibility criteria accross trials is needed for efficient trial matching, thus Clinical Trial Markup Language (CTML) #PrecisionMedicine #PrecisionOnc #AACR18

aftimosp's tweet image. Homogeneous structuring of eligibility criteria accross trials is needed for efficient trial matching, thus Clinical Trial Markup Language (CTML) #PrecisionMedicine #PrecisionOnc #AACR18
aftimosp's tweet image. Homogeneous structuring of eligibility criteria accross trials is needed for efficient trial matching, thus Clinical Trial Markup Language (CTML) #PrecisionMedicine #PrecisionOnc #AACR18
aftimosp's tweet image. Homogeneous structuring of eligibility criteria accross trials is needed for efficient trial matching, thus Clinical Trial Markup Language (CTML) #PrecisionMedicine #PrecisionOnc #AACR18
0
0
1
0
0
JCO_ASCO's profile picture. @ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, @JCOPO_ASCO, @JCOOA_ASCO.
Journal of Clinical Oncology
@JCO_ASCO
Jul 7, 2021

Availability of genomic testing resources varied by practice type and by rurality, highlighting opportunities to advance equitable delivery of precision medicine fal.cn/3gAjs #precisiononc #JCOPO

JCO_ASCO's tweet image. Availability of genomic testing resources varied by practice type and by rurality, highlighting opportunities to advance equitable delivery of precision medicine fal.cn/3gAjs #precisiononc #JCOPO
0
1
0
0
0
JeremyKratz's profile picture. physician scientist of liver and pancreatic cancers, husband, father, recovering wolverine.
Jeremy Kratz
 @JeremyKratz
May 12, 2023

Learning from legend Dr. Michael Heinrich on building precision strategies at GI Precision Oncology Summit. @utswcancer #rarecancer #VHA #precisiononc

JeremyKratz's tweet image. Learning from legend Dr. Michael Heinrich on building precision strategies at GI Precision Oncology Summit. @utswcancer #rarecancer #VHA #precisiononc
0
0
4
0
412

Something went wrong.


Something went wrong.


United States Trends